Dark Sweet Cherries Cancer-Fighting Effects

Researchers at Texas A&M University published a study on September 2, 2026, in the International Journal of Molecular Sciences revealing that anthocyanins found in dark sweet cherries can reduce tumor growth, metastasis, and treatment resistance in triple-negative breast cancer. The findings demonstrated that mice given anthocyanin-rich extracts before tumor implantation developed tumors more slowly and maintained stable body weight compared to controls. The research team, led by Dr. Giuliana Noratto and Dr. Lauren Stranahan, aimed to evaluate whether natural plant compounds could serve as a preventive approach and improve the efficacy of standard chemotherapy drugs like doxorubicin. Triple-negative breast cancer lacks estrogen receptors, progesterone receptors, and HER2 expression, making it highly aggressive, difficult to treat, and prone to spreading rapidly to organs such as the lungs and brain. Histological analysis of tumor tissues revealed that anthocyanin treatment significantly decreased the activity of genes associated with metastasis and therapy resistance. Furthermore, the combination of dark sweet cherry extracts and chemotherapy slowed tumor progression more effectively than chemotherapy alone, while successfully preventing the weight loss typically induced by standard drug treatments in animal models. These preliminary results suggest that incorporating diet-derived bioactive compounds into multimodal cancer therapies could offer valuable biological pathways for future oncological treatments. Although further clinical investigations regarding safety, absorption, and human efficacy are necessary, the study highlights the critical advantage of interdisciplinary research in tackling complex diseases.